Back
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Novartis AG Industry Stock Comparison
Buy
65
IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF
Last Price:
$92.08
Seasonality Move:
0.37%
Buy
64
NVSEF
Novartis AG
Last Price:
$110.25
Seasonality Move:
4.44%
Buy
65
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV)
is a Buy
Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $91.97. The Score for IVOV is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
IVOV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $110.25. The Score for NVSEF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IVOV Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $91.97The current trend is moderately bullish and IVOV is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $110.25The current trend is moderately bullish and NVSEF is experiencing slight buying pressure.
IVOV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.83 | Buy |
Relative Strength Index (14 RSI): | 52.64 | Buy |
Chaikin Money Flow: | 3453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.08 - 93.54) | Buy |
Bollinger Bands (100): | (88.3 - 97.88) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 52.67 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.4 - 112.76) | Buy |
Bollinger Bands (100): | (102.26 - 112.38) | Buy |
IVOV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.24 | Sell |
20-day SMA: | 92.11 | Sell |
50-day SMA: | 89.67 | Buy |
200-day SMA: | 94.97 | Sell |
8-day EMA: | 92.31 | Sell |
20-day EMA: | 91.71 | Buy |
50-day EMA: | 91.21 | Buy |
200-day EMA: | 92.7 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.11 | Buy |
20-day SMA: | 109.27 | Buy |
50-day SMA: | 109.01 | Buy |
200-day SMA: | 107.61 | Buy |
8-day EMA: | 110.07 | Buy |
20-day EMA: | 109.53 | Buy |
50-day EMA: | 108.93 | Buy |
200-day EMA: | 106.37 | Buy |
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |